Denali Therapeutics (DNLI) EBITDA Margin (QoQ) (2018 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Denali Therapeutics | 3.82 Bn | 3.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -784,196.00 |
| Jun 30, 2023 | 36,268.00 |
| Mar 31, 2023 | 63,714.00 |
| Dec 31, 2022 | 5.50 Mn |
| Sep 30, 2022 | -5.58 Mn |
| Jun 30, 2022 | 5,300.00 |
| Mar 31, 2022 | 44,643.00 |
| Dec 31, 2021 | 98,620.00 |
| Sep 30, 2021 | -119,791.00 |
| Jun 30, 2021 | 700.24 Mn |
| Mar 31, 2021 | -700.29 Mn |
| Dec 31, 2020 | 117.54 Mn |
| Sep 30, 2020 | -117.44 Mn |
| Jun 30, 2020 | 10.72 Mn |
| Mar 31, 2020 | -10.70 Mn |
| Dec 31, 2019 | 4.73 Mn |
| Sep 30, 2019 | 985,603.00 |
| Jun 30, 2019 | -5.75 Mn |
| Mar 31, 2019 | -96,628.00 |
| Dec 31, 2018 | 301,581.00 |
| Sep 30, 2018 | 37,966.00 |
| Jun 30, 2018 | 50,415.00 |